Story perspectives

Cambridge Organoids Reverse Axon Decline with Gene Inhibition, Lynestrenol

6/5/2026

Summary

Story summary

The team discovered a gene network that limits axon growth in mature human neurons.
University of Cambridge researchers built linked brain-spinal cord organoids, inhibited key genes and applied the approved hormone drug lynestrenol, which together restored damaged axon regrowth and boosted regeneration.
The organoid system produced neural circuits that caused contractions in miniature muscle clusters.
Neurons retained axon-regrowth ability until roughly day 150 of development, after which capacity sharply declined.

1 of 1

Story summary

The team discovered a gene network that limits axon growth in mature human neurons.
University of Cambridge researchers built linked brain-spinal cord organoids, inhibited key genes and applied the approved hormone drug lynestrenol, which together restored damaged axon regrowth and boosted regeneration.
The organoid system produced neural circuits that caused contractions in miniature muscle clusters.
Neurons retained axon-regrowth ability until roughly day 150 of development, after which capacity sharply declined.